OncoGenex Pharmaceuticals Inc. said that its cancer drug OGX-011 has received a “fast track” designation from the U.S. Food & Drug Administration. (OGXI)

Lees meer..

The H. Lee Moffitt Cancer Center & Research Institute has earned financing needed to study the influences of physician, patient and policy factors on recommendations of HPV vaccination in the years following licensure of the vaccine. (MRK) (CELG)

Lees meer..

Celera Corp. has elected Peter Barton Hutt, a food and drug law attorney and former FDA chief counsel, as a director of the company. (CRA)

Lees meer..

Codexis Inc., which focuses on biocatalysis technology, and Arch Pharmalabs Ltd., an active pharmaceutical ingredients and intermediates manufacturer, on Monday announced a new strategic collaboration.

Lees meer..

AngioScore Inc. is petitioning the Food and Drug Administration to refuse competitor Abbott Laboratories the extension of its patent covering so-called “rapid exchange” angioplasty catheters. (ABT)

Lees meer..

AngioScore Inc. is petitioning the Food and Drug Administration to refuse competitor Abbott Laboratories the extension of its patent covering so-called “rapid exchange” angioplasty catheters. (ABT)

Lees meer..

Avantis Medical Systems Inc., which has developed a tiny camera to help colonoscopies do a better job of locating potential cancers, named medical device veterans Scott Dodson as president and CEO and Larry Tannenbaum as senior vice president and CFO. (BSX)

Lees meer..

Oregon Health & Science University’s earnings from industry-sponsored research rose nearly 50 percent in fiscal year 2008 and is up close to 250 percent from five years ago, reflecting steady increases in private sector partnerships on new medical therapies, diagnostics and devices.

Lees meer..

WellDyneRx Inc. will create more than 670 jobs when it opens a new facility in Lakeland, more than tripling the Colorado company’s prescription mail order capacity.

Lees meer..

Six sites remain in the running for the proposed National Bio and Agro-Defense Facility. Sites are evaluated based on proximity to research capabilities; proximity to work force; acquisition, construction and operations considerations; and community acceptance. Each site is touted by a consortium of local stakeholders dedicated to attracting the NBAF and assisting the Department of Homeland Security with environmental analysis, site acquisition and other needs.

Lees meer..